Keros Therapeutics, Inc.KROSNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$70.62M
↑ 205% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
$-67.53M
Historical baseline
PeriodValueYoY Change
2025$70.62M+133.5%
2024$-210.83M-24.1%
2023$-169.94M-48.0%
2022$-114.79M-103.6%
2021$-56.37M-20.8%
2020$-46.66M-341.7%
2019$-10.56M-524.7%
2018$-1.69M-